How a Peninsula biotech hopes to give bacteria a boost to boot diseases
The company's first-in-humans clinical trial targets a compound associated with kidney stones.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Biotechnology | Clinical Trials | Health Management | Kidney Stones | Urology & Nephrology